911119

Hydroxylamin -hydrochlorid

free-flowing, Redi-Dri^™, ACS reagent, 98.0%

• Synonym(e): Hydroxylammoniumchlorid
• Lineare Formel: NH₂OH · HCl
• CAS-Nummer: 5470-11-1
• Molekulargewicht: 69.49
• Beilstein: 3539763
• MDL-Nummer: MFCD00051089
• UNSPSC-Code: 12352116
• NACRES: NA.21

Eigenschaften

• Qualität: ACS reagent
• Dampfdruck: 0.001 hPa ( 50 °C)
• Produktlinie: Redi-Dri^™
• Assay: 98.0%
• Form: powder
• pH-Wert: 2.5-3.5 (20 °C, 50 g/L)
• mp (Schmelzpunkt): 155-157 °C (dec.) (lit.)
• Dichte: 1.67 g/mL at 25 °C (lit.)
• Anionenspuren: sulfur compounds (as SO₄^2-): ≤0.005%
• Kationenspuren: Fe: ≤5 ppm; NH₄⁺:, passes test; heavy metals: ≤5 ppm
• SMILES String: Cl.NO
• InChI: 1S/ClH.H3NO/c;1-2/h1H;2H,1H2
• InChIKey: WTDHULULXKLSOZ-UHFFFAOYSA-N

Beschreibung

Anwendung

Redi-Dri^™ is an innovative packaging product line that helps eliminate clumping material by adding extra packaging process steps without any chemical additives, anti-clumping agents, or hydrophobic compounds. Redi-Dri^™ offers a more convenient and safer way to handle the products.

Biochem./physiol. Wirkung

MAO-Inhibitor; hemmt die Thrombozytenaggregation.

Rechtliche Hinweise

Redi-Dri is a trademark of Sigma-Aldrich Co. LLC

Sicherheitshinweise

• Piktogramme: GHS08,GHS05,GHS07,GHS09
• Signalwort: Warning
• H-Sätze: H290,H302 + H312,H315,H317,H319,H351,H373,H410
• P-Sätze: P273 - P280 - P301 + P312 - P302 + P352 + P312 - P305 + P351 + P338 - P308 + P313
• Gefahreneinstufungen: Acute Tox. 4 Dermal - Acute Tox. 4 Oral - Aquatic Acute 1 - Aquatic Chronic 2 - Carc. 2 - Eye Irrit. 2 - Met. Corr. 1 - Skin Irrit. 2 - Skin Sens. 1 - STOT RE 2 Oral
• Zielorgane: spleen
• Lagerklassenschlüssel: 4.1A - Other explosive hazardous materials
• WGK: WGK 3
• Flammpunkt (°F): Not applicable
• Flammpunkt (°C): Not applicable